Market
Scenario:
The
pericardium is a double-layered, tough, collagenous membrane, which surrounds
the heart. They play an important role in the protection of the health from
external shock. Nowadays, a number of companies manufacture artificial tissue
membrane, which is widely used in the surgical procedures of pelvic floor
reconstruction and bariatric stomach reduction. Many factors are responsible
for the diseases, which includes infections, heart surgery, trauma, cancer and
many other diseases. Pericarditis is the most common type of the disease. It
affects people of all ages, however, men between 20 years-50 years are more
likely to develop the disease. In 15%-30% cases, it develops into chronic
pericarditis. Increasing prevalence of pericarditis across the globe is a major
driver of the market. According to the Health Grades Inc, 1 in every 2,000
individual have pericarditis. Additionally, high healthcare expenditure,
increasing demand for the better treatment, and rising number of patients with
heart diseases are providing support for the growth of the market. However,
available treatments are costly and are not affordable to peoples in developing
countries. Thus, the high cost of the treatment may slow the growth of the
market.
The
global pericardium diseases market is expected to grow at a CAGR of ~8.2 %
during the forecast period 2017-2023.
Segmentation
The global pericardium diseases market is segmented on the basis of types, treatment, and end users.
The global pericardium diseases market is segmented on the basis of types, treatment, and end users.
On the
basis of the types, the market is segmented into acute pericarditis,
hemopericardium, pericarditis, tuberculous pericarditis, and others.
On the
basis of the treatment, the market is segmented into diagnostic test, and
disease treatment. The diagnostic treatment is further segmented into the
physical exam, EKG, chest X-ray, echocardiography, cardiac CT, cardiac MRI, and
others. The diseases treatment is sub-segmented into anti-inflammatory drugs,
pericardium patches, surgery, and others.
On the
basis of the end users, the market is segmented into hospital & clinics,
ambulatory centers, and others.
Key
Players in Global Pericardium Market
Some of
key the players in the market are Smith and Nephew (U.K), Teva Pharmaceutical
(Isreal), GlaxoSmithKline Plc. (U.K), Novartis AG (Switzerland), Eli Lilly and
Company (U.S.), Arthrex, Inc.(U.S.), Medtronic (U.K), Edwards Lifesciences
(U.S.), Abbott Laboratories (U.S.), Johnson & Johnson Services, Inc.
(U.S.), C.R. Bard Inc (U.S.)Allergan (U.S.), Integra Lifesciences (U.S.),
Livanova(U.K), and Zimmer Biomet (U.S.)
Table Of Content
Chapter 1. Report
Prologue
Chapter 2. Market
Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research
Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market
Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor
Analysis
5.1 Porters Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry
About US:
Market
Research Future (MRFR), enable customers to unravel the complexity of various
industries through Cooked Research Report (CRR), Half-Cooked Research Reports
(HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market
Research & Consulting Services.
Contact Us:
Market
Research Future
Office
No. 528, Amanora Chambers
Magarpatta
Road, Hadapsar,
Pune
- 411028
Maharashtra,
India
Phone:
+1 646 845 9312
Email:
sales@marketresearchfuture.com
No comments:
Post a Comment